Hauser-Ross Eye Institute   Report issue

Academic/Hospital Phase 4
Founded: Chicago IL United States (1980)

Organization Overview

First Clinical Trial
2019
NCT04184999
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

SR Cornea Conslutants | SR Cornea Consultants

Active Ingredients

Drugs in Phase 4 Trials (2)

dexamethasone (1 trial)

prednisolone (hydeltra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dry Eye Syndromes (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2